Gleevec (imatinib)
GLEEVEC (imatinib mesylate) – a kinase inhibitor drug commonly used to treat certain types of leukemia, myeloproliferative diseases, and certain other malignancies. FDA approved uses: Gleevec is indicated for: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase; Patients with Philadelphia chromosome positive chronic myeloid leukemia […]